These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10840043)

  • 1. Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations.
    Matias PM; Donner P; Coelho R; Thomaz M; Peixoto C; Macedo S; Otto N; Joschko S; Scholz P; Wegg A; Bäsler S; Schäfer M; Egner U; Carrondo MA
    J Biol Chem; 2000 Aug; 275(34):26164-71. PubMed ID: 10840043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively.
    Shkolny DL; Beitel LK; Ginsberg J; Pekeles G; Arbour L; Pinsky L; Trifiro MA
    J Clin Endocrinol Metab; 1999 Feb; 84(2):805-10. PubMed ID: 10022458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer.
    Ruizeveld de Winter JA; Janssen PJ; Sleddens HM; Verleun-Mooijman MC; Trapman J; Brinkmann AO; Santerse AB; Schröder FH; van der Kwast TH
    Am J Pathol; 1994 Apr; 144(4):735-46. PubMed ID: 7512791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of the androgen receptor at amino acid 708 (Gly-->Ala) abolishes partial agonist activity of steroidal antiandrogens.
    Terouanne B; Nirdé P; Rabenoelina F; Bourguet W; Sultan C; Auzou G
    Mol Pharmacol; 2003 Apr; 63(4):791-8. PubMed ID: 12644579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to treatment in patients with partial androgen insensitivity due to mutations in the DNA-binding domain of the androgen receptor.
    Lundberg Giwercman Y; Nikoshkov A; Lindsten K; Byström B; Pousette A; Knudtzon J; Alm J; Wedell A
    Horm Res; 2000; 53(2):83-8. PubMed ID: 10971094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor binding characteristics in the cytosol of the rat dorsolateral prostate gland and the Dunning R-3327 prostatic adenocarcinoma.
    Rowley DR; Thompson SA; Lubaroff DM; Heidger PM
    Prostate; 1984; 5(1):101-11. PubMed ID: 6607463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands.
    Marhefka CA; Moore BM; Bishop TC; Kirkovsky L; Mukherjee A; Dalton JT; Miller DD
    J Med Chem; 2001 May; 44(11):1729-40. PubMed ID: 11356108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells.
    Ueda T; Mawji NR; Bruchovsky N; Sadar MD
    J Biol Chem; 2002 Oct; 277(41):38087-94. PubMed ID: 12163482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific recognition of androgens by their nuclear receptor. A structure-function study.
    Poujol N; Wurtz JM; Tahiri B; Lumbroso S; Nicolas JC; Moras D; Sultan C
    J Biol Chem; 2000 Aug; 275(31):24022-31. PubMed ID: 10787411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the glucocorticoid response in a mutant human androgen receptor (AR(ccr)) derived from an androgen-independent prostate cancer.
    Matias PM; Carrondo MA; Coelho R; Thomaz M; Zhao XY; Wegg A; Crusius K; Egner U; Donner P
    J Med Chem; 2002 Mar; 45(7):1439-46. PubMed ID: 11906285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A naturally occurring mutation in the human androgen receptor of a subject with complete androgen insensitivity confers binding and transactivation by estradiol.
    Bonagura TW; Deng M; Brown TR
    Mol Cell Endocrinol; 2007 Jan; 263(1-2):79-89. PubMed ID: 17011702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete androgen insensitivity syndrome caused by a novel mutation in the ligand-binding domain of the androgen receptor: functional characterization.
    Rosa S; Biason-Lauber A; Mongan NP; Navratil F; Schoenle EJ
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4378-82. PubMed ID: 12213902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
    Gregory CW; Johnson RT; Mohler JL; French FS; Wilson EM
    Cancer Res; 2001 Apr; 61(7):2892-8. PubMed ID: 11306464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of normal and point-mutated human androgen receptors expressed in the baculovirus system.
    Beitel LK; Sabbaghian N; Alarifi A; Alvarado C; Pinsky L; Trifiro M
    J Mol Endocrinol; 1995 Oct; 15(2):117-28. PubMed ID: 8800637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of organochlorine pesticides on human androgen receptor activation in vitro.
    Lemaire G; Terouanne B; Mauvais P; Michel S; Rahmani R
    Toxicol Appl Pharmacol; 2004 Apr; 196(2):235-46. PubMed ID: 15081270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the functional link between androgen receptor coactivator and ligand-binding sites in prostate cancer and androgen insensitivity.
    He B; Gampe RT; Hnat AT; Faggart JL; Minges JT; French FS; Wilson EM
    J Biol Chem; 2006 Mar; 281(10):6648-63. PubMed ID: 16365032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand responsiveness in human prostate cancer: structural analysis of mutant androgen receptors from LNCaP and CWR22 tumors.
    McDonald S; Brive L; Agus DB; Scher HI; Ely KR
    Cancer Res; 2000 May; 60(9):2317-22. PubMed ID: 10811100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of [3H]-methyltrienolone (R1881) by human breast cancers.
    Miller WR; Telford J; Hawkins RA
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1473-8. PubMed ID: 6605855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen modulation of prostate cancer cell androgen receptor content is cell line specific.
    Lin AL; Shain SA
    Mol Cell Endocrinol; 1989 May; 63(1-2):75-83. PubMed ID: 2787764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of the androgen-receptor gene in a family with receptor-positive partial androgen insensitivity: an unusual type of intronic mutation.
    Brüggenwirth HT; Boehmer AL; Ramnarain S; Verleun-Mooijman MC; Satijn DP; Trapman J; Grootegoed JA; Brinkmann AO
    Am J Hum Genet; 1997 Nov; 61(5):1067-77. PubMed ID: 9345099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.